
About Deventure Drugs Private Limited
Data last updated:
Deventure Drugs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PTC363445.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rohit Mukul and Verinder Chhabra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
For more details, the company can be reached via its website zeelab.co.in.
Company details
Contact details
Deventure Drugs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Social Media
- Registered Address913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Deventure Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Deventure Drugs Private Limited
FY 2024 filings availableDeventure Drugs Private Limited reported revenue of ₹691 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Deventure Drugs Private Limited, buy the company report.
Board of directors of Deventure Drugs Private Limited
Deventure Drugs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Mukul Also directs: Asian Reclamation Private Limited, Deventure Hospitality Private Limited, Palm Land Hotel & Resorts LLP and 2 more | Director | 25 Apr 2020 | 6 Years 6 Months | Current |
| Verinder Chhabra Also directs: Klokter Life Sciences Private Limited, Klokter Healthcare Private Limited, Zee Biosciences Private Limited and 5 more | Director | 25 Apr 2020 | 6 Years 6 Months | Current |
Auditor
Deventure Drugs Private Limited is audited by TAGEJA R & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TAGEJA R & CO | FY 2022 | 036385N |
Shareholding
The shareholding of Deventure Drugs Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Deventure Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Deventure Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deventure Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Deventure Drugs Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
No GST registration is on our record for Deventure Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Deventure Drugs Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Rohit Mukul was appointed as Director on 25 Apr 2020.
Frequently asked questions
Deventure Drugs is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2020 (6+ years old) and is registered under CIN U24304DL2020PTC363445.
Deventure Drugs has 2 current directors:
- Rohit Mukul - Director
- Verinder Chhabra - Director
The latest financial statements of Deventure Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Deventure Drugs is U24304DL2020PTC363445. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deventure Drugs was incorporated on 25 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Rohit Mukul was appointed as Director on 25 Apr 2020. Verinder Chhabra was appointed as Director on 25 Apr 2020.
Deventure Drugs can be reached through the website zeelab.co.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Deventure Drugs is at 913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
Deventure Drugs operates in the pharma industry, in the drug formulation and development segment.
Deventure Drugs is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

